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Aim. Involvement of Xanthine Oxidase (XO; EC1.1.3.22) in cellular proliferation and differentiation has been
suggested by the numerous investigations. We have proposed that XO might have undoubtedly important role
during the development, maturation as well as the   death of human embryos brain cells. Methods. Human abor-
tion material was utilized for the cultivation of brain cells (E90). XO activity was measured by the formation of  
uric acid in tissue. Cell death was detected by the utility of Trypan Blue dye. Results. Allopurinol suppressed the
XO activity in the brain tissue (0.12 ± 0.02; 0.20 ± 0.03 resp., p £ 0.05). On day 12th the number of cells in the
culture treated with the Allopurinol at the early stage of development was higher in comparison with the Control   
(2350.1 ± 199.0 vs 2123 ± 96) and higher in comparison with the late period of   treatment (1479.6 ± 103.8, p <
< 0.05). In all groups, the number of the dead cells was less than in Control, indicating   the protective nature of
Allopurinol as an inhibitor of XO. Conclusions. Allopurinol initiates cells proliferation in case of the early
treatment of the human brain derived cell culture whereas at the late stages it has an opposite effect. 
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Introduction. Neuronal death during the processes of
proliferation and cell migration is pronounced in emb-
ryonic developing brain [1]. 
It was demonstrated that in chick embryos, about
45 % of the retinal ganglion cells are lost between E10
and E16 [2], whereas isthmo-optic nucleus loss is about 
55 % between E12 and E17 [3]. Neuronal death occurs
at the time of the formation of connectivity with other
neurons, during the development of the synapses. 
The mechanism of reactive oxygen species produc- 
tion might be mediated due to the activity of the Xanthi-
ne Oxidase (XO; EC1.1.3.22). Activity of this enzyme
might be similar at the number of  diseases, including
myocardial ischemia, stroke, chronic heart failure, hy-
pertension, hypercholesterolemia, atherosclerosis, dia-
betes etc.  
Furthermore, an  involvement of XO in cellular pro-
liferation and differentiation has been suggested [4].
Moreover, Moriwaki et al. demonstrated the presence
of XO in brain, as well as in other organs, by the utility
of immunochemical methods [4]. 
Taking into account that XO is responsible for the
ROS formation its involvement into the delayed reco-
very of injured nerves in old rats as well as into tissue re-
pair might be suggested [5]. 
We have proposed  that XO might play undoubted-
ly important role during the cell growth, development,
maturation as well as in death of human brain derived
cell culture. 
Materials and methods. Trypan Blue staining. A
cell suspension was prepared in BSS (Hank’s Balanced 
Salt Solution, Product No. H9269, «Sigma», USA).
After all it was transfered 0.5 ml of 0.1 % Trypan Blue
solution to a test tube and  0.3 ml of BSS was added to
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0.2 ml of the cell suspension (dilution factor = 5) and
mixed thoroughly. The cell suspension-Trypan Blue
mixture was kept for at least 5 min [6]. The cultured
cells were trypsinized with 0.25% trypsine solution and 
collected from the plates. Cells were stained with the
2% Trypan Blue dye for visualization of the viable/non
viable cells. 
Cell culturing. All procedures with the utility of bio-
materials were carried out in accordance with the De-
claration of Helsinki.  Human embryos were obtained
from elective abortions with the informed consent of
the women seeking abortion. Moreover, only fetuses 
with the age of formation no more than 12 weeks were
used as a biomaterial [7].
Brains of the human embryos (E90) were with-
drawn, and placed in Neurobasal medium (NB, pre-
natal, «Gibco Life Technologies», USA) containing
0.05 % bovine serum albumin (BSA). The tissue was
isolated and incubated at 37 °C for 20 min in NB con-
taining 0.05 % BSA, 0.15 % trypsine. The tissue was
resuspended in fresh NB and mechanically disintegra-
ted using a Pasteur pipette. The supernatant was discar- 
ded and the cell suspension resuspended in NB medium 
containing 1 % BSA. This procedure was repeated 3 ti-
mes. Human brain cells were collected (1,000 rpm,
10 min), washed and cultured at 37 °C, 5 % CO2  in
35 mm Petri dishes pre-coated with poly-L-lysine («Sig- 
ma») containing 0.09 % Na2HPO4, 1 % glucose, 0.4 %
KCl, 0.06 % KH2PO4, 0.4 % MgSO4  ´ 7H2O and
0.001 % gentamicin sulfate. A day later the medium
was replaced by NB containing 2 % B27-supplement
(«Gibco») and the cells’ number was calculated on the
days second and 12th [8].  
Xanthine Oxidase activity estimation by determi-
nation of the uric acid quantity in the brain tissue [9].
Xanthine and Allopurinol were incubated with the
biological solution for one hour at 37 °C, after the
Specol 2000 estimated all the absorption at 660 nm. 
Homogenization of the human embryos brain. For
100 ml of the buffer 0.87 g NaCl, 0.06 g KH2PO4,
0.09 g Na2HPO4, 5 mM MgCl2, 0.1 M Tris aminome-
thane, 1 ml of Triton X 100, 200 ug of Trypsine inhibi-
tors, 0.001 M KNaC4H4O6  ´4H2O were added. Glass-
glass homogenization was performed during 20 min.
The mixture was centrifuged at G = 8000 for 20 min.
Supernatant was used for the experiments. 
Microscopy. It was used Polarizing microscope Bio-
lar PI (PZO, Poland; magnification 1.25  ´ 40 or
1.25 ´  20). The pictures were taken on 12th day. Number 
of the cells was calculated by the utility of Pixcavator
program, allowing authomatically to calculatate the
size as well as the number of the cells. 
Detection and quantification of proteins by Brad-
ford.  The protein content in  samples was determined
in the Specol 2000 (Poland) at  590 nm   [10].
Statistics. We have used t-test (student) for pair com- 
parison as well as ONE-WAY-ANOVA for estimation
of the significance. The results were considered stati-
stically significant when p was lower or equal to 0.05. 
Results and discussion. The  influence of Allopu-
rinol on the activity of XO.  We have measured the XO
activity in the wide range of human embryos brains to
determine whether there is any correlation between the
activity and the age of the latter. According to our re-
sults there is no any difference. The activity of XO,
disclosed as  the formation of total uric acid in the solu-
tion, was suppressed by 40 % (Fig. 1). The black co-
lumn represents an effect of Allopurinol whereas the
grey one – the total activity of XO (0.12 ± 0.02; 0.20 ±
± 0.03 respectively, p = 0.05). 
The second series of experiments devoted to exami-
nation of the XOR inhibitor effect in the cells culture.
We used two types of XO inhibitor – Allopurinol. The
cells obtained from human E12 embryonic brain were
treated with Allopurinol in different concentrations
(high and low) as well as in different time points (1st to
0.000
0.005
0.010
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Fig. 1.  Activity of XO in the human embryos brain. Grey column
represents [XO] activity in the brain (n = 16); black column points to
the suppressive abilities of Allopurinol. Here are represented standard
errors of the mean and p < 0.05 calculated by t-student test
6th days – as the first period and 6th to 12th days – as the
second period) to delineate the functional properties
and the role of XO activity in the development and sur-
vival of the brain cells. 
The results were very interesting. Allopurinol in
low concentration during the first period of time did ini-
tiate the growth of cells (2350.1 ± 199.0), whereas du-
ring the second time period the same concentration of
the inhibitor had the opposite influence and significantly 
reduced (1479.6 ± 103.8) the number of brain cells in the 
culture in comparison with the Control (2123 ± 96, p <
< 0.05) and low dosage treatment during the early period 
(p < 0.05). The high concentration of Allopurinol had no 
significant effects (1907.3 ± 194.4; 1992 ± 43) in compa- 
rison with the Control group (Fig. 2, see inset ).
It is interesting that all concentrations of Allopuri-
nol at any stage of the cells growth and development de-
creased the cell death in comparison with the control in sta-
tistically significant way (control –  3538.33 ± 356.61; ear-
ly stage of the treatment: low concentration of Allopu-
rinol – 2385.20 ± 389.13,  high – 1033.67± 235.15; la-
te stage of the treatment: low concentration of Allopu-
rinol – 389.80 ± 66.80,  high – 876.67 ± 221.78; p <
< 0.05 between all groups vs Control (Fig. 3, see inset). 
Our experimental results demonstrated the XO pre- 
sence in the developing human embryos brain. In ac-
cordance with the known data and our results its acti-
vity might be inhibited by Allopurinol. 
It is well known that XO might initiate the for-
mation of synapses and connections between the neu-
ronal cells [4] and introduce regenerative or develop-
mental activities.
On the other hand it might serve as a source initia-
ting cells’ death [11].
Thus, the same enzyme – XO – has a bifacial func-
tional activity – death and proliferation. 
 In our experiments partial suppression of the XO
activity and ROS generation during the early stage of
cells growth protects the culture, whereas at the late sta-
ges, possibly, activity of the same enzyme and formed
products trigger more effective cell development, axo-
nal and dendritic ends outgrowth, formation of the sy-
napses and differentiation. 
Further experiments are necessary for detailed deli- 
neation of the above-mentioned phenomena. 
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Активність ксан ти нок си да зи ре гу лює ріст клітин моз ку ембріона
лю ди ни
Ре зю ме
Мета. Важ ливість функціону ван ня ксан ти нок си да зи (КО) в про -
це сах проліфе рацї і ди фе ренціації клітин до ве де но ба гать ма вче -
ни ми. Ми при пус ти ли, що КО ви ко нує не замінну роль у про це сах
роз вит ку, дозріван ня, а та кож за ги белі клітин  моз ку ембріона
лю ди ни. Ме то ди. Абортивний ма теріал лю ди ни за сто со ва но для
куль ти ву ван ня клітин (E90). Активність КО виз на ча ли за кількі-
стю се чо вої кис ло ти в тка нині; клітин ну смерть – з ви ко рис тан -
ням три па но во го синь о го. Ре зуль та ти. Алопуринол, згідно із на -
шим досліджен ням, при гнічує ак тивність КО (0,12 ± 0,02; 0,20 ± 
± 0,03 відповідно, p  £  0,05). На 12-й день кількість клітин у куль -
турі, у яку вно си ли ало пу ри нол, по чи на ю чи з пер ших етапів роз -
вит ку, була ви щою, ніж у кон тролі  (2350,1 ± 199,0 vs 2123 ± 96),
та пе ре ви щу ва ла кількість клітин у куль турі, до якої до да ва ли
ало пу ри нол на більш пізніх стадіях рос ту і роз вит ку (1479,6 ±
± 103,8, p < 0,05). В усіх куль ту рах кількість мер твих клітин ви-
яви ла ся ни жчою порівня но з кон тро лем, що вка зує на за хисні
власти вості ало пу ри но лу як інгібітора КО. Вис нов ки. Алопуринол
ініціює клітин ну проліфе рацію на ранніх ета пах роз вит ку клітин -
ної куль тури та при гнічує клітин ний ріст на пізніших стадіях. 
Клю чові сло ва: ксан ти нок си да за, ембріональні клітини моз ку
лю ди ни, проліфе рація, клітин на смерть.
К. Э. Да ни е лян, Г. А. Ке вор кян
Активность ксан ти нок си да зы ре гу ли ру ет рост кле ток моз га 
эм бри о на че ло ве ка 
Ре зю ме
Цель. Важ ность функ ци о ни ро ва ния ксан ти нок си да зы (КО) в
про цес сах про ли фе ра ции и диф фе рен ци а ции кле ток до ка за на ря -
дом уче ных. Мы пред по ло жи ли, что КО вы пол ня ет не за ме ни мую
роль в про цес сах раз ви тия, со зре ва ния, а так же смер ти кле ток
моз га эм бри о на че ло век. Ме то ды. Че ло ве чес кий абор тив ный ма -
те ри ал при ме нен для куль ти ви ро ва ния кле ток (E90). Активность 
КО опре де ля ли по ко ли чес тву мо че вой кис ло ты в тка ни; кле точ -
ную смерть – с ис поль зо ва ни ем три па но во го си не го. Ре зуль та -
ты. Аллопуринол, со глас но на шим ис сле до ва ни ям, под ав ля ет ак-
тив ность КО (0,12 ± 0,02; 0,20 ± 0,03 со от ве тствен но, p  £  0,05).
На 12-й день ко ли чес тво кле ток в куль ту ре, в ко то рую вно си ли
аллопу ри нол, на чи ная с пер вых эта пов раз ви тия, было выше, чем в
контро ле  (2350,1 ± 199,0 vs 2123 ± 96), и пре вы ша ло ко ли чес тво
кле ток в куль ту ре, в ко то рую до бав ля ли ал лопури нол на бо лее позд- 
них ста ди ях рос та и раз ви тия (1479,6 ± 103,8, p < 0,05). Во всех
куль ту рах ко ли чес тво мер твых  кле ток ока за лось ниже, чем в
кон тро ле, что ука зы ва ет на за щит ные сво йства ал ло пу ри но ла
как ин ги би то ра КО. Вы во ды. Аллопуринол ини ци и ру ет кле точ -
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Fig. 2. The influence of Allopurinol on the cell number at day 12th. 
magnification 60  ´1.25  ´20. The first group of the cells was trea-
ted during the entire period of the culturing, from day 1st until the
day 12th (b, c), whereas the second group was treated during the
second period, which was starting from day 6th until day 12th (d, e). 
Also, it was used t-student test to calculate the significance of the
results. Results were considered significant, if p < 0.05. The results 
related with the low concentration of Allopurinol in comparison
with each other and Control (a) were statistically significant
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Fig. 3. The number of dead cells in the field, stained with the Trypan
Blue c on 12th day after seeding human embryonic neuronal cells.  Mag- 
nification 60  ´1.25  ´20. The pictures were taken on day 12th (A). There
were calculated results of the observation of 3 different fields from the
plates for every group (B). The first column represents the control gro-
up. The second column represents the cells treated with low, the third –
with high concentrations of Allopurinol reflecting the conditions when
the cells in the culture were receiving the Allopurinol from day 1st to
day 12th. 4th and 5th columns represent the group of the cells receiving
the low and hight concentrations of Allopurinol from day 6th to day 12th. 
The results were accepted as a statistically significant when  p < 0.05
a b c
d e f
10 :m
Fig..1. HEK293 cells were treated with rapa-
mycin (b), LY294002 (c), 2-deoxyglucose (d), 
CHX (e) and sodium arsenite (f) during 30 min.
Picture a represent cells treated with DMSO.
After treatment cells were fixed with 3.7 % FA,
and stained with anti-RCD-8 antibodies. As se-
condary were used FITC-conjugated antibo-
dies. Cell nuclei were stained with Hoechst
33258. Magnification  ´100
Figure to article D. O. Gudkova  et al.
Figures to article K. E. Danielyan,  G. A. Kevorkian
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ную про ли фе ра цию на ран них эта пах раз ви тия кле точ ной куль -
ту ры и под ав ля ет кле точ ный рост на бо лее по здних ста ди ях. 
Клю че вые сло ва: ксан ти нок си да за, эм бри о наль ные клет ки
моз га че ло ве ка, про ли фе ра ция, кле точ ная смерть.
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